Your prescription in another country: the written walkthrough

Myth · Pointless: a prescription only counts in the country that signed it, I will have to see a doctor over there.

The myth: “a prescription stops at the border” It is the first sentence of the official page, and it says the opposite: a prescription delivered by a doctor in one EU country is valid in all other EU countries. A local consultation remains a fallback; it is not a compulsory first step.

“A prescription delivered by a doctor in one EU country is valid in all other EU countries.”

In plain words: your prescription is entitled to travel with you. The blanket refusal of “foreign paper” does not exist in the text.

Myth · I just take the empty box: the pharmacist will read the brand, it is the same all over Europe.

The myth: “same brand everywhere, the box will do” The official page warns in its second sentence: a medicine prescribed in one country might not be available in another, or it may have another name. That is exactly why the cross-border prescription carries the medicine's common name rather than the brand name. The empty box tells your brand's story; the prescription names the molecule.

“However, a medicine prescribed in one country might not be available or it may have another name.”

In plain words: brands change from country to country. What travels well is the medicine's common name, written on a real prescription.

Myth · Nothing: the e-prescription lives in the European health cloud, every pharmacy in the Union can access it.

The myth: “the European health cloud already exists for everyone” The official page is more careful than the myth: the e-prescription may not be available outside your home country, and that is precisely why it advises asking for a paper copy. Interoperable systems exist between some countries, not between all. The day your e-prescription can be read everywhere, the official page will say so; until then, it says print.

“as the e-prescription may not be available outside your home country.”

In plain words: interoperability advances country by country, it is not general. Paper never runs into a compatibility issue.

Myth · Check nothing at all: EU law makes him dispense immediately, without a single question.

The myth: “recognition means dispensing blind” The directive itself reserves the case of legitimate and justified doubts about the authenticity, content or comprehensibility of a prescription. Checking that a foreign prescription is genuine and understandable is not discrimination: it is an exception written into the very text your right stands on. What the text prohibits is refusal on principle, not vigilance.

“(b) based on legitimate and justified doubts about the authenticity, content or comprehensibility of an individual prescription.”

In plain words: the pharmacist is entitled to make sure the prescription is genuine and readable. Answer his questions: they serve your dispensing.

Myth · Hand over exactly my brand: a foreign prescription rules out substitution by a generic.

The myth: “foreign prescription = brand set in stone” The directive says the opposite: recognition does not affect national rules governing prescribing and dispensing, including generic or other substitution. The pharmacist applies his country's rules, as for any local prescription. That is precisely why the cross-border prescription carries the common name: the molecule travels, the brand does not.

“The recognition of such prescriptions shall not affect national rules governing prescribing and dispensing, if those rules are compatible with Union law, including generic or other substitution.”

In plain words: at the counter, the country's dispensing rules apply, generics included. Your prescription is recognised; it does not import the rules of your home country.

Myth · No: prescription recognised, so identical coverage to home, right here at the till.

The myth: “recognised = reimbursed the same, immediately” The very text that founds recognition is the one that bounds it: the recognition of prescriptions shall not affect the rules on reimbursement of medicinal products. The country's counter applies its prices; your coverage is discussed with your insurer, not with the pharmacist. Mixing the two loses the one battle of the day that was already won: getting the medicine.

“The recognition of prescriptions shall not affect the rules on reimbursement of medicinal products. Reimbursement of costs of medicinal products is covered by Chapter III of this Directive.”

In plain words: the right to obtain the medicine and the right to be reimbursed live in different chapters. At the counter, you pay the country's price.

Myth · He must at least apply my home validity: my prescription is good for a year, full stop.

The myth: “my national validity travels with the prescription” The official page says exactly the opposite: dispensation is subject to the rules of the country where the prescription is used, and the pharmacist applies national rules, for example time or dosage limitations. Your prescription is recognised; the counter's rules remain those of the counter's country.

“The dispensation of prescriptions is subject to the rules of the country where they are dispensed. This means that a pharmacist will apply national rules when dispensing your medicine – for example, time or dosage limitations to dispensation of prescriptions.”

In plain words: validity and dispensing limits are those of the country where you present the prescription. Do not expect a foreign counter to run on your country's rules.

Myth · Your sister: authorised in one EU country means authorised in all, he has to order it.

The myth: “one national authorisation counts for all twenty-seven” The directive opens with the very condition the myth skips: IF the medicinal product is authorised to be marketed on their territory, Member States shall ensure that prescriptions issued elsewhere can be dispensed. The recognition obligation covers the prescription, not the catalogue: a medicine not authorised in the counter's country remains out of reach, prescription or not.

“If a medicinal product is authorised to be marketed on their territory, in accordance with Directive 2001/83/EC or Regulation (EC) No 726/2004, Member States shall ensure that prescriptions issued for such a product in another Member State for a named patient can be dispensed on their territory in compliance with their national legislation in force”

In plain words: the opening “if” does all the work. Recognition applies to medicines authorised in the country where you are.

Myth · Nobody can ever refuse: faced with a foreign prescription, the pharmacist has no right of refusal at all.

The myth: “the foreign prescription is irresistible” The directive expressly preserves the pharmacist's right to refuse, for ethical reasons, to dispense a product prescribed in another Member State, on one condition of equality: he must have had the same right of refusal had the prescription been issued in the Member State of affiliation. It is not a special right against foreign prescriptions: it is the same refusal as for local ones, no more, no less.

“the recognition of prescriptions shall not affect a pharmacist’s right, by virtue of national rules, to refuse, for ethical reasons, to dispense a product that was prescribed in another Member State, where the pharmacist would have the right to refuse to dispense, had the prescription been issued in the Member State of affiliation.”

In plain words: the pharmacist keeps the right of refusal he would have had facing a prescription from his own country. Equality cuts both ways: no discrimination against your prescription, no free pass for it either.